IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.314
-0.007 (-2.09%)
Apr 28, 2026, 4:00 PM EDT - Market closed
IGC Pharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$5.25
Upside
+1,574.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5 → $5.25 | Strong Buy | Maintains | $5 → $5.25 | +1,574.64% | Apr 8, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.75 → $5 | Strong Buy | Maintains | $4.75 → $5 | +1,494.90% | Feb 23, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.5 → $4.75 | Strong Buy | Maintains | $4.5 → $4.75 | +1,415.15% | Dec 9, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4.25 → $4.5 | Strong Buy | Maintains | $4.25 → $4.5 | +1,335.41% | Aug 26, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +1,016.43% | Mar 6, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4 → $4.25 | Strong Buy | Maintains | $4 → $4.25 | +1,255.66% | Feb 24, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.75 → $4 | Strong Buy | Maintains | $3.75 → $4 | +1,175.92% | Dec 5, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.5 → $3.75 | Strong Buy | Maintains | $3.5 → $3.75 | +1,096.17% | Sep 3, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.25 → $3.5 | Strong Buy | Maintains | $3.25 → $3.5 | +1,016.43% | Jul 29, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +1,016.43% | Jul 17, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $3.25 | Strong Buy | Reiterates | $3.25 | +936.68% | Jun 21, 2024 |